COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
12 nov. 2024 07h30 HE
|
COSCIENS Biopharma Inc.
Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12,...
PatchMD Launch New Shopify Website To Keep Up With Demand For The 2022-2023 Holiday Season
24 nov. 2022 09h00 HE
|
PatchMD
Las Vegas, Nevada, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Founded by a team of experts with over 60 years of combined experience in the over-the-counter pharmaceutical and medical device products...
Pharmaceutical Excipients Market to Outstrip $9,873.53 Million by 2027 Growing Sturdy at 5.5% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
04 juin 2021 09h30 HE
|
The Insight Partners
Pune, India., June 04, 2021 (GLOBE NEWSWIRE) -- Pharmaceutical Excipients Market: Key InsightsAccording to our new research study on “Pharmaceutical Excipients Market to 2027 – Global Analysis and...
Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis Technology Platform
21 janv. 2021 04h30 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California-based life science...
Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019
15 avr. 2019 06h15 HE
|
Biofrontera AG
Leverkusen, Germany, April 15, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Changes in the composition of the Supervisory Board
27 mars 2019 09h05 HE
|
Biofrontera AG
Leverkusen, Germany, March 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that the...
Biofrontera to Participate in Two Upcoming Investor Conferences
26 nov. 2018 13h08 HE
|
Biofrontera AG
Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
Correction of news release from August 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018
03 sept. 2018 05h35 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01
22 févr. 2018 09h00 HE
|
Mount Tam Biotechnologies Inc.
NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased...
Bio-Pharmaceutical Logistics Market: Rising Unmet Medical Needs Pushes Bio-Pharmaceutical Companies Improve Logistics, Observes TMR
28 sept. 2016 05h35 HE
|
Transparency Market Research
Albany - New York, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research discusses the logistics market for the bio-pharmaceuticals industry in its recent research report. It explains...